ArticleJournal of cancer research and clinical oncology2009

Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo.

Michael Pohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.